Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Hepatitis E-associated encephalopathy in a renal transplant recipient.

de Vries MA, Samijn JP, de Man R, Boots JM.

BMJ Case Rep. 2014 Apr 30;2014. pii: bcr2014204244. doi: 10.1136/bcr-2014-204244.

2.

Severe hypophosphataemia after intravenous iron administration.

Blazevic A, Hunze J, Boots JM.

Neth J Med. 2014 Jan;72(1):49-53.

3.

Preservation of renal function and cardiovascular risk factors.

van Hooff JP, Gelens M, Boots JM, van Duijnhoven EM, Dackus J, Christiaans MH.

Transplant Proc. 2006 Sep;38(7):1987-91. Review.

PMID:
16979974
4.

Is tacrolimus superior to ciclosporin microemulsion in preventing long-term acute renal transplant rejection?

Boots JM.

Nat Clin Pract Nephrol. 2005 Nov;1(1):16-7. No abstract available.

PMID:
16932358
5.
6.

Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile.

Artz MA, Boots JM, Ligtenberg G, Roodnat JI, Christiaans MH, Vos PF, Moons P, Borm G, Hilbrands LB.

Am J Transplant. 2004 Jun;4(6):937-45.

7.

Increase in tacrolimus trough levels after steroid withdrawal.

van Duijnhoven EM, Boots JM, Christiaans MH, Stolk LM, Undre NA, van Hooff JP.

Transpl Int. 2003 Oct;16(10):721-5. Epub 2003 Jun 24.

PMID:
12827231
8.

Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus.

Artz MA, Boots JM, Ligtenberg G, Roodnat JI, Christiaans MH, Vos PF, Blom HJ, Sweep FC, Demacker PN, Hilbrands LB.

J Am Soc Nephrol. 2003 Jul;14(7):1880-8.

9.
10.

Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study.

Boots JM, Christiaans MH, Van Duijnhoven EM, Van Suylen RJ, Van Hooff JP.

Transplantation. 2002 Dec 27;74(12):1703-9.

PMID:
12499885
11.

Pretransplant pharmacokinetics: does it predict the dose of tacrolimus after renal transplantation?

Boots JM, Christiaans MH, Undre NA, van Hooff JP.

Transplant Proc. 2002 Dec;34(8):3171-2. No abstract available.

PMID:
12493409
12.

Randomized conversion from cyclosporine to tacrolimus in renal transplant patients: improved lipid profile and unchanged plasma homocysteine levels.

Artz MA, Boots JM, Ligtenberg G, Roodnat JI, Christiaans MH, Hené RJ, Blom HJ, Demacker PN, Hilbrands LB.

Transplant Proc. 2002 Aug;34(5):1793-4. No abstract available.

PMID:
12176579
13.

Evidence that fasting does not significantly affect trough levels of tacrolimus in stable renal transplant recipients.

van Duijnhoven EM, Christiaans MH, Boots JM, van Hooff JP.

Transplant Proc. 2002 Aug;34(5):1723-5. No abstract available.

PMID:
12176552
14.

Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study.

Boots JM, Christiaans MH, van Duijnhoven EM, van Suylen RJ, van Hooff JP.

Transplant Proc. 2002 Aug;34(5):1698-9. No abstract available.

PMID:
12176542
15.

Risk of adrenal insufficiency with steroid maintenance therapy in renal transplantation.

Boots JM, van den Ham EC, Christiaans MH, van Hooff JP.

Transplant Proc. 2002 Aug;34(5):1696-7. No abstract available.

PMID:
12176541
16.

A late episode of post-transplant diabetes mellitus during active hepatitis C infection in a renal allograft recipient using tacrolimus.

van Duijnhoven EM, Christiaans MH, Boots JM, Goossens VJ, Undre NA, van Hooff JP.

Am J Kidney Dis. 2002 Jul;40(1):195-201.

PMID:
12087579
17.

Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients.

Boots JM, van Duijnhoven EM, Christiaans MH, Nieman FH, van Suylen RJ, van Hooff JP.

Transpl Int. 2001 Dec;14(6):370-83.

PMID:
11793034
18.

Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction.

Boots JM, van Duijnhoven EM, Christiaans MH, Wolffenbuttel BH, van Hooff JP.

J Am Soc Nephrol. 2002 Jan;13(1):221-7.

19.

Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression.

van Duijnhoven EM, Christiaans MH, Boots JM, Nieman FH, Wolffenbuttel BH, van Hooff JP.

J Am Soc Nephrol. 2002 Jan;13(1):213-20.

20.

A comparison between office and ambulatory blood pressure measurements in renal transplant patients with chronic transplant nephropathy.

Kooman JP, Christiaans MH, Boots JM, van Der Sande FM, Leunissen KM, van Hooff JP.

Am J Kidney Dis. 2001 Jun;37(6):1170-6.

PMID:
11382685
21.

Influence of tacrolimus on glucose metabolism before and after renal transplantation: a prospective study.

Duijnhoven EM, Boots JM, Christiaans MH, Wolffenbuttel BH, Van Hooff JP.

J Am Soc Nephrol. 2001 Mar;12(3):583-8.

22.

Dosing and management guidelines for tacrolimus in renal transplant patients.

van Hooff JP, Boots JM, van Duijnhoven EM, Christiaans MH.

Transplant Proc. 1999 Nov;31(7A):54S-57S. No abstract available.

PMID:
10576046
23.

Unaccountable severe hypercalcemia in a patient treated for hypoparathyroidism with dihydrotachysterol.

Boots JM, Burghouts JT, Jansen JL.

Neth J Med. 1999 Jan;54(1):16-20.

PMID:
10048291
24.

An automated computerized method using Finapres for measuring cardiovascular reflexes.

Netten PM, Boots JM, Bredie SJ, den Arend JA, Mol MJ, Thien T, Hoefnagels WH, Lutterman JA.

Clin Sci (Lond). 1992 Aug;83(2):157-63.

PMID:
1327630
25.

Obesity, restrained eating and the cumulative intake curve.

Westerterp KR, Nicolson NA, Boots JM, Mordant A, Westerterp MS.

Appetite. 1988 Oct;11(2):119-28.

PMID:
3239963

Supplemental Content

Loading ...
Support Center